mRNA vaccination facilitates the prevention and control of infectious diseases at an unprecedented speed

In recent years, amidst the progresses of biotechnology versus the emergence and evolution of diseases, the pursuit of mRNA (messenger RNA) vaccines has become a focal point, particularly after their revolutionary function during the COVID-19 pandemic. mRNA vaccines have assumed a pivotal role against infectious diseases, and represent an avenue of exploration that holds great promise. The merits of mRNA vaccines are manifold, and encompass rapid development, unparalleled flexibility and adaptability, the elicitation of potent immune responses, cost-effective manufacturing, and the potential for personalized medicine. The global scientific community has become inspired by the possibilities of expeditious vaccine development, resulting in an extensive tapestry of research and development. However, realizing the full potential of mRNA vaccines is not without scientific and regulatory pitfalls, and necessitates a concerted effort to surmount these challenges. Nevertheless, incremental advances bear testament to the ever-evolving landscape of mRNA vaccine advancement in the battle against COVID-19. We believe that this technology will further play a significant role in the field of infectious diseases. This article aims to describe mRNA vaccine mechanisms and their applications against infectious diseases. • mRNA vaccines are encompassing rapid development, unparalleled flexibility and adaptability. • Elicit potent immune responses, cost-effective manufacturing, and the tantalizing potential for personalized medicine. • mRNA vaccines effectiveness mechanism make vaccine developing simply. • mRNA vaccines antigenic design is endless. • Potency is notably pronounced in the unyielding battle against COVID-19, particularly for high-frequency mutation.